Rudisill McAndrew 4
4 · 180 Life Sciences Corp. · Filed Aug 12, 2025
Insider Transaction Report
Form 4
Rudisill McAndrew
DirectorChief Executive Officer
Transactions
- Award
Warrant to Purchase Common Stock
2025-08-08+957,002→ 957,002 total(indirect: By LLC)Exercise: $3.44From: 2025-08-08→ Common Stock (957,002 underlying)
Holdings
- 452,830(indirect: By LLC)
Common Stock
- 4,807,873(indirect: By LLC)
Warrant to Purchase Common Stock
Exercise: $2.77From: 2025-08-04→ Common Stock (4,807,873 underlying) - 37,735(indirect: By LLC)
Common Stock
- 37,735(indirect: By LLC)
Common Stock
- 37,735(indirect: By LLC)
Common Stock
Footnotes (8)
- [F1]The Reporting Person is the managing partner of BER I LLC ("BER"), and therefore may be deemed to beneficially own the securities held by BER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by BER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F2]The Reporting Person is the managing partner of GER I LLC ("GER"), and therefore may be deemed to beneficially own the securities held by GER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by GER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]The Reporting Person is the managing partner of MRR I LLC ("MRR"), and therefore may be deemed to beneficially own the securities held by MRR. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by MRR, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F4]The Reporting Person is the managing partner and founder of Pelagic Capital Advisors LLC ("Pelagic"), and therefore may be deemed to beneficially own the securities held by Pelagic. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by Pelagic, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F5]These warrants are currently exercisable, subject to a blocker provision that prevents PCAO (defined below) from exercising the warrants if it would be more than a 4.99% beneficial owner of the outstanding shares of the Issuer's common stock following such exercise, which percentage may be increased to up to 19.99% with at least 61 days prior written notice to the Issuer.
- [F6]The warrants have no expiration date.
- [F7]Issued in consideration for advisory and consulting services agreed to be rendered by PCAO.
- [F8]The Reporting Person is the managing partner of PCAO LLC ("PCAO"), and therefore may be deemed to beneficially own the securities held by such entity. Mr. Rudisill disclaims beneficial ownership of the shares of securities owned directly by PCAO, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.